Nuvation Bio Statistics

Total Valuation

Nuvation Bio has a market cap or net worth of $926.28 million. The enterprise value is $320.45 million.

Market Cap	926.28M
Enterprise Value	320.45M

Important Dates

The next estimated earnings date is Monday, August 5, 2024, after market close.

Earnings Date	Aug 5, 2024
Ex-Dividend Date	n/a

Share Statistics

Nuvation Bio has 247.67 million shares outstanding. The number of shares has increased by 0.14% in one year.

Shares Outstanding	247.67M
Shares Change (YoY)	+0.14%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	27.21%
Owned by Institutions (%)	52.86%
Float	148.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.54
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 38.58, with a Debt / Equity ratio of 0.01.

Current Ratio	38.58
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -11.30% and return on invested capital (ROIC) is -15.65%.

Return on Equity (ROE)	-11.30%
Return on Assets (ROA)	-11.00%
Return on Capital (ROIC)	-15.65%
Revenue Per Employee	n/a
Profits Per Employee	-$1.35M
Employee Count	51
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +101.93% in the last 52 weeks. The beta is 1.40, so Nuvation Bio's price volatility has been higher than the market average.

Beta (5Y)	1.40
52-Week Price Change	+101.93%
50-Day Moving Average	3.12
200-Day Moving Average	2.23
Relative Strength Index (RSI)	63.90
Average Volume (20 Days)	2,029,589

Short Selling Information

The latest short interest is 12.44 million, so 5.02% of the outstanding shares have been sold short.

Short Interest	12.44M
Short Previous Month	6.12M
Short % of Shares Out	5.02%
Short % of Float	8.40%
Short Ratio (days to cover)	6.08

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-93.50M
Pretax Income	-68.87M
Net Income	-68.87M
EBITDA	-68.73M
EBIT	-68.87M
Earnings Per Share (EPS)	-$0.32

Full Income Statement

Balance Sheet

The company has $596.98 million in cash and $3.53 million in debt, giving a net cash position of $593.44 million or $2.40 per share.

Cash & Cash Equivalents	596.98M
Total Debt	3.53M
Net Cash	593.44M
Net Cash Per Share	$2.40
Equity (Book Value)	594.04M
Book Value Per Share	2.40
Working Capital	592.29M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$64.37 million and capital expenditures -$70,000, giving a free cash flow of -$64.44 million.

Operating Cash Flow	-64.37M
Capital Expenditures	-70,000
Free Cash Flow	-64.44M
FCF Per Share	-$0.29

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Nuvation Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.14%
Shareholder Yield	-0.14%
Earnings Yield	-7.54%
FCF Yield	-7.05%

Analyst Forecast

The average price target for Nuvation Bio is $6.60, which is 76.47% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.60
Price Target Difference	76.47%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	5.10%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2